Optimization of clinical risk-factor interpretation and radiological findings with machine learning for PIRADS category 3 patients.
Journal:
The Prostate
PMID:
34783053
Abstract
BACKGROUND: Due to the low cancer-detection rate in patients with PIRADS category 3 lesions, we created machine learning (ML) models to facilitate decision-making about whether to perform prostate biopsies or monitor clinical information without biopsy results.
Authors
Keywords
Aged
Humans
Image-Guided Biopsy
Machine Learning
Magnetic Resonance Imaging
Male
Prostate
Prostate-Specific Antigen
Prostatic Neoplasms
Public Reporting of Healthcare Data
Quality Improvement
Research Design
Risk Assessment
Sensitivity and Specificity
Ultrasonography, Interventional
Unnecessary Procedures